N-(4-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺(112696-91-0)名称与标识符
名称
中文别名:
伊马替尼杂质胺;2-甲基-N1-[4-(3-吡啶)-2-嘧啶]-1,4-苯二胺;4-氯丁基甲基醚;N-(4-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺;
英文别名:
2-Methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,4-diamine;N-(4-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine;2-METHYL-N1-[4-(3-PYRIDINYL)-2-PYRIMIDINYL]-1,4-BENZENEDIAMINE;1,4-Benzenediamine,2-methyl-N1-[4-(3-pyridinyl)-2-pyrimidinyl]-;2-methyl-1-N-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,4-diamine;N-(4-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
;Imatinib intermediates;Imatinib 1,4-diamine genotoxic impurity;3-Methyl-4-[4-(3-pyridyl)pyriMidin-2-ylaMino]aniline;112696-91-0;(2R)-2-[(Benzyloxycarbonyl)amino]-3-[(tert-butoxycarbonyl)amino]propionic?acid;2-Methyl-N~1~-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,4-diamine;2-Methyl-N-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,4-diamine;AC-14176;N-(2-Methyl-4-aminophenyl)-4-(3-pyridyl)-2-pyrimidineamine;AKOS015961548;1,4-Benzenediamine, 2-methyl-N1-[4-(3-pyridinyl)-2-pyrimidinyl]-;FDU39CAY7P;SCHEMBL3860532;DTXSID80652142;
标识符
InChIKey:
KTGVVCLIFBRODR-UHFFFAOYSA-N
Inchi:
1S/C16H15N5/c1-11-9-13(17)4-5-14(11)20-16-19-8-6-15(21-16)12-3-2-7-18-10-12/h2-10H,17H2,1H3,(H,19,20,21)
SMILES:
N(C1N=CC=C(C2C=NC=CC=2)N=1)C1C=CC(=CC=1C)N